Efficacy of vaccination against canine parvovirus

SIR, - I find it ironic that the National Office of Animal Health ( noah ) should warn the profession of an increase in the prevalence of canine parvovirus type 2 ( cpv-2 ) when it is the advocacy of early vaccination (a final dose at 10 weeks for puppies) by its members that contributes to the prob...

Full description

Saved in:
Bibliographic Details
Published in:Veterinary record 2006-10, Vol.159 (17), p.570-571
Main Author: Thompson, Hal
Format: Article
Language:English
Subjects:
Age
Animals
Antibodies, Viral - blood
Confidence intervals
Dog Diseases - prevention & control
Dogs
Infections
Parvoviridae Infections - prevention & control
Parvoviridae Infections - veterinary
Parvovirus, Canine - immunology
Parvovirus, Canine - pathogenicity
Vaccination - methods
Vaccination - veterinary
Vaccines
Viral Vaccines - administration & dosage
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:SIR, - I find it ironic that the National Office of Animal Health ( noah ) should warn the profession of an increase in the prevalence of canine parvovirus type 2 ( cpv-2 ) when it is the advocacy of early vaccination (a final dose at 10 weeks for puppies) by its members that contributes to the problem.
ISSN:0042-4900
2042-7670
DOI:10.1136/vr.159.17.570-b